Results 191 to 200 of about 31,828 (224)

TMPRSS2 Expression in Lung Tissue of Prostatic Adenocarcinoma Patients: Androgen Deprivation Therapy and Relevance to SARS-CoV-2 Infection. [PDF]

Curr Issues Mol Biol
Riveros Angel M, Loeffler D, Charifa A, Sinit RB, Amery T, Cengiz B, Beer TM, Thomas GV.   +7 more
europepmc   +1 more source

Targeting envelope lipids with 2,6‑di‑<i>O</i>‑methyl‑3‑acetyl‑β‑cyclodextrin impairs infectivity of SARS‑CoV‑2 and Japanese encephalitis virus. [PDF]

J Virol
Kusakari D, Kishimoto N, Oshiro K, Udeda Y, Takamune N, Motoyama K, Misumi S.   +6 more
europepmc   +1 more source

High-Fidelity and Cost-Effective Engineering of SARS-CoV-2. [PDF]

Viruses
Olguin-Nava M, Hennig T, Börtlein C, Bohn P, Ambi UB, Gabel A, Günter LM, Gribling-Burrer AS, Schmidt N, Caliskan N, Dölken L, Munschauer M, Smyth RP.   +12 more
europepmc   +1 more source

Identification of p-aminobenzylamine derivatives as dual non-covalent inhibitors of the transmembrane host proteases TMPRSS2 and HAT proteases with anti-viral potential. [PDF]

RSC Med Chem
Carvaillo H, Dussol A, Chaaya N, Kadri S, Soualmia F, Masurier N, El Amri C.   +6 more
europepmc   +1 more source

Placental Vulnerability to SARS-CoV-2: Viral Entry Pathways and Immune Activation. [PDF]

Viruses
Natarajan M, Jayashankar B, Nataraj R.
europepmc   +1 more source

Extending the Targets for Coronavirus Antivirals Beyond That of Approved Drugs: Insights From Preclinical Research. [PDF]

Microb Biotechnol
Brüssow H.
europepmc   +1 more source

Effect of the S2' site cleavage on SARS-CoV-2 spike. [PDF]

Nat Commun
Shi W, Jonaid GM, Kibria MG, Allen J, Peng H, Rits-Volloch S, Zhu H, Wang S, Walsh RM, Lu J, Chen B.   +10 more
europepmc   +1 more source

Genetic Association Between TMPRSS2 Polymorphisms and COVID-19 Severity in Brazilian Health Workers. [PDF]

Viruses
Telles AFC, Menezes Junior BS, Dos Santos CA, Alves MRM, Sena LOC, Cipolotti R.   +5 more
europepmc   +1 more source